Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Dec 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how we understand and measure sleep health, particularly for individuals dealing with chronic insomnia or circadian rhythm disorders. Researchers want to translate a tool called the Sleep Regularity Questionnaire (SRQ) into French and ensure it is reliable for French-speaking patients. This questionnaire will help identify sleep irregularities, which can affect both mental and physical health.
To participate in the study, you must be at least 18 years old, fluent in French, and have a condition that requires monitoring your sleep for 14 days. It's important that you can complete questionnaires on your own and have no current serious mental or neurological disorders. If you join the study, you will help researchers validate this new tool, which could ultimately help improve sleep health for many people. Your participation is voluntary, and you can ask questions or express any concerns before deciding to take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient ≥ 18 years of age
- • Patient with indication for 14-day actimetry for chronic insomnia or circadian rhythm disorder
- • Patients with an indication for 14-day actimetry to assess sleep-wake rhythms, for example prior to a 36-hour polysomnographic recording to diagnose central hypersomnia (narcolepsy or idiopathic hypersomnia).
- • Patient affiliated to or benefiting from a social security scheme
- • Patient with French as mother tongue, able to read and write French.
- • Patient able to understand and complete questionnaires independently
- • Patient informed and not opposed to participating in the study
- Exclusion Criteria:
- • Current psychiatric disorder (mood disorders, anxiety, psychosis, sleep-interfering use disorder) assessed during interview with investigator
- • Current neurological disorder affecting sleep (neurodegenerative disease, stroke, epilepsy) assessed during interview with investigator
- • Unstable cardiovascular or respiratory diseases
- • Pregnant or breast-feeding women
- • Adults under guardianship or curatorship
- • Opposition to participation expressed by healthy patient/volunteer
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported